Discover the full directors' dealings record of 대한약품, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 대한약품 has logged 1 insider filings. Market capitalisation: €163.8bn. The latest transaction was reported on 6 March 2026 (Other). Among the most active insiders: 대한약품. All data is accessible without an account.